CAJ | 학술논문

目的:观察中西医结合治疗慢性乙型重型肝炎的临床疗效.方法:将86例慢性乙型重型肝炎患者随机分为治疗组43例,对照组43例.治疗组采用西医常规治疗,加上中医中药辨证治疗.对照组仅予以西医常规治疗.2组治疗前后比较临床存活率和病死率,并观察肝功能及凝血功能变化.结果:治疗结束后,治疗组存活率72.1%,疗效优于对照组的55.9%,且治疗组ALT、TBil、Alb、PTA等实验室指标的定量检测均较对照组有明显改善(P<0.05);同时治疗组治疗前后其肝功能、凝血功能也有显著改善(P<0.05).结论:中西医结合治疗慢性乙型重型肝炎有较好疗效.
목적:관찰중서의결합치료만성을형중형간염적림상료효.방법:장86례만성을형중형간염환자수궤분위치료조43례,대조조43례.치료조채용서의상규치료,가상중의중약변증치료.대조조부여이서의상규치료.2조치료전후비교림상존활솔화병사솔,병관찰간공능급응혈공능변화.결과:치료결속후,치료조존활솔72.1%,료효우우대조조적55.9%,차치료조ALT、TBil、Alb、PTA등실험실지표적정량검측균교대조조유명현개선(P<0.05);동시치료조치료전후기간공능、응혈공능야유현저개선(P<0.05).결론:중서의결합치료만성을형중형간염유교호료효.
Objective:To observe the effect of integrated Chinese and western medicine on chronic severe hepatitis B.Methods:Eight-six cases were divided at random to treat group (n=43), who received a combined regime of routine western treatment and Chinese formulas, and control group (n=43) who were given routine western treatments only. Survival rate, mortality rate, liver function and PTA were measured before and after treatment. Results:Survival rate for the treat group was 72.1% compared with 55.9% for the control group. For the treat group, ALT, TBil, Alb, PTA were significantly lowered and liver functions improved compared with those of the control group (P<0.05).Conclusion:Integrated Chinese and western medicine is effective for treating Chronic severe hepatitis B.